| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Hitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida, Jun Ishigooka, Hisashi Higuch. Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trial. The Journal of clinical psychiatry. vol 67. issue 10. 2007-02-23. PMID:17107250. |
the efficacy and safety of switching to olanzapine were investigated in patients with first-episode schizophrenia who failed to attain an adequate clinical response to an initial therapeutic trial of risperidone (2-6 mg/day for 12 weeks). |
2007-02-23 |
2023-08-12 |
Not clear |
| Hung-Yu Chan, Wei-Wen Lin, Shih-Ku Lin, Tzung-Jeng Hwang, Tung-Ping T Su, Shu-Chuan Chiang, Hai-Gwo Hw. Efficacy and safety of aripiprazole in the acute treatment of schizophrenia in Chinese patients with risperidone as an active control: a randomized trial. The Journal of clinical psychiatry. vol 68. issue 1. 2007-02-20. PMID:17284127. |
efficacy and safety of aripiprazole in the acute treatment of schizophrenia in chinese patients with risperidone as an active control: a randomized trial. |
2007-02-20 |
2023-08-12 |
Not clear |
| Delbert G Robinson, Margaret G Woerner, Barbara Napolitano, Raman C Patel, Serge M Sevy, Handan Gunduz-Bruce, Jose M Soto-Perello, Alan Mendelowitz, Ali Khadivi, Rachel Miller, Joanne McCormack, Beth S Lorell, Martin L Lesser, Nina R Schooler, John M Kan. Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes. The American journal of psychiatry. vol 163. issue 12. 2007-02-16. PMID:17151160. |
randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes. |
2007-02-16 |
2023-08-12 |
Not clear |
| Robert Chapli. Risperidone improves symptoms in people who are hospitalised during an acute exacerbation of schizophrenia. Evidence-based mental health. vol 10. issue 1. 2007-02-12. PMID:17255384. |
risperidone improves symptoms in people who are hospitalised during an acute exacerbation of schizophrenia. |
2007-02-12 |
2023-08-12 |
Not clear |
| John P Docherty, Cynthia A Bossie, Bernard Lachaux, Philippe Bouhours, Young Zhu, Robert Lasser, Georges M Gharabaw. Patient-based and clinician-based support for the remission criteria in schizophrenia. International clinical psychopharmacology. vol 22. issue 1. 2007-02-02. PMID:17159460. |
this analysis characterizes patients with schizophrenia or schizoaffective disorder treated with risperidone who met remission criteria. |
2007-02-02 |
2023-08-12 |
human |
| Xiaohong Wang, Robert Savage, Andrey Borisov, Jill Rosenberg, Bobbi Woolwine, Melanie Tucker, Roberta May, Jacqueline Feldman, Charles B Nemeroff, Andrew H Mille. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study. Journal of psychiatric research. vol 40. issue 7. 2007-01-29. PMID:16762371. |
efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study. |
2007-01-29 |
2023-08-12 |
human |
| Antonio Ciudad, José M Olivares, Manuel Bousoño, Juan C Gómez, Enrique Alvare. Improvement in social functioning in outpatients with schizophrenia with prominent negative symptoms treated with olanzapine or risperidone in a 1 year randomized, open-label trial. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 8. 2007-01-29. PMID:16820255. |
improvement in social functioning in outpatients with schizophrenia with prominent negative symptoms treated with olanzapine or risperidone in a 1 year randomized, open-label trial. |
2007-01-29 |
2023-08-12 |
Not clear |
| Michael S Ritsner, Anatoly Gibe. The effectiveness and predictors of response to antipsychotic agents to treat impaired quality of life in schizophrenia: A 12-month naturalistic follow-up study with implications for confounding factors, antidepressants, anxiolytics, and mood stabilizers. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 8. 2007-01-29. PMID:16842897. |
this study examined specific predictors of the efficacy of risperidone (rp), olanzapine (ol) and first-generation antipsychotic agents (fgas), the role of confounding factors, and concomitant agents such as antidepressants, anxiolytics, and mood stabilizers in the treatment of health related quality of life (hrql) impairment of schizophrenia patients. |
2007-01-29 |
2023-08-12 |
Not clear |
| Blanka Kores Plesnicar, Bojan Zalar, Katja Breskvar, Vita Dolza. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment. Journal of psychopharmacology (Oxford, England). vol 20. issue 6. 2007-01-26. PMID:16478753. |
in total 131 outpatients meeting the dsm iv criteria for schizophrenia or schizoaffective disorder and receiving maintenance therapy with haloperidol, fluphenazine, zuclopethixole or risperidone were genotyped for 14 polymorphic cyp2d6 alleles. |
2007-01-26 |
2023-08-12 |
Not clear |
| Shinsuke Nakanishi, Hiroshi Kunugi, Robin M Murray, Seiji Nojima, Toyoaki Ogawa, Toshihiko Takahash. Effects of switching from conventional antipsychotics to risperidone in Japanese patients with chronic schizophrenia. Psychiatry and clinical neurosciences. vol 60. issue 6. 2007-01-23. PMID:17109710. |
effects of switching from conventional antipsychotics to risperidone in japanese patients with chronic schizophrenia. |
2007-01-23 |
2023-08-12 |
Not clear |
| Shinsuke Nakanishi, Hiroshi Kunugi, Robin M Murray, Seiji Nojima, Toyoaki Ogawa, Toshihiko Takahash. Effects of switching from conventional antipsychotics to risperidone in Japanese patients with chronic schizophrenia. Psychiatry and clinical neurosciences. vol 60. issue 6. 2007-01-23. PMID:17109710. |
fifty patients with chronic schizophrenia completed the study in which combination therapy with other antipsychotics was allowed if monotherapy with risperidone was not tolerated. |
2007-01-23 |
2023-08-12 |
Not clear |
| Shinsuke Nakanishi, Hiroshi Kunugi, Robin M Murray, Seiji Nojima, Toyoaki Ogawa, Toshihiko Takahash. Effects of switching from conventional antipsychotics to risperidone in Japanese patients with chronic schizophrenia. Psychiatry and clinical neurosciences. vol 60. issue 6. 2007-01-23. PMID:17109710. |
switching from conventional antipsychotics to risperidone reduced schizophrenia symptoms, antiparkinsonian medication, and polypharmacy. |
2007-01-23 |
2023-08-12 |
Not clear |
| Ira D Glick, Ziv Shkedy, Andreas Schreine. Differential early onset of therapeutic response with risperidone vs conventional antipsychotics in patients with chronic schizophrenia. International clinical psychopharmacology. vol 21. issue 5. 2007-01-10. PMID:16877896. |
differential early onset of therapeutic response with risperidone vs conventional antipsychotics in patients with chronic schizophrenia. |
2007-01-10 |
2023-08-12 |
Not clear |
| Ira D Glick, Ziv Shkedy, Andreas Schreine. Differential early onset of therapeutic response with risperidone vs conventional antipsychotics in patients with chronic schizophrenia. International clinical psychopharmacology. vol 21. issue 5. 2007-01-10. PMID:16877896. |
data were pooled from four double-blind active comparator-controlled clinical trials involving 757 patients with schizophrenia treated for up to 8 weeks with either risperidone (4-6 mg/day) or a conventional antipsychotic such as haloperidol (10 or 20 mg/day), perphenazine (mean dose 28 mg/day), or zuclopenthixol (mean dose 38 mg/day). |
2007-01-10 |
2023-08-12 |
Not clear |
| Corrado Barbui, Camilla Linta. Decision models in the evaluation of psychotropic drugs : useful tool or useless toy? The European journal of health economics : HEPAC : health economics in prevention and care. vol 7. issue 3. 2007-01-09. PMID:16862446. |
a current contribution in the european journal of health economics employs a decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia. |
2007-01-09 |
2023-08-12 |
Not clear |
| Stephen M Beard, Fiona Maciver, Johannes Clouth, Eckart Rüthe. A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in Germany. The European journal of health economics : HEPAC : health economics in prevention and care. vol 7. issue 3. 2007-01-09. PMID:16896764. |
a decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in germany. |
2007-01-09 |
2023-08-12 |
Not clear |
| Stephen M Beard, Fiona Maciver, Johannes Clouth, Eckart Rüthe. A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in Germany. The European journal of health economics : HEPAC : health economics in prevention and care. vol 7. issue 3. 2007-01-09. PMID:16896764. |
second-generation atypical antipsychotics such as clozapine, olanzapine, risperidone, quetiapine, ziprasidone, amisulpride and ariprazole offer the potential to reduce the significant health care resource demands in the treatment of schizophrenia through improved levels of initial clinical response and reduced levels of long-term acute relapse. |
2007-01-09 |
2023-08-12 |
Not clear |
| Tamar Mozes, Tanya Ebert, Sabbagh-Etun Michal, Baruch Spivak, Abraham Weizma. An open-label randomized comparison of olanzapine versus risperidone in the treatment of childhood-onset schizophrenia. Journal of child and adolescent psychopharmacology. vol 16. issue 4. 2007-01-09. PMID:16958565. |
an open-label randomized comparison of olanzapine versus risperidone in the treatment of childhood-onset schizophrenia. |
2007-01-09 |
2023-08-12 |
Not clear |
| Burak Dogangün, Sabri Hergüner, Murat Atar, Bülent Kara, M Umut Aksoy, Levent Kayaalp, Umran Tüzü. The treatment of psychogenic polydipsia with risperidone in two children diagnosed with schizophrenia. Journal of child and adolescent psychopharmacology. vol 16. issue 4. 2007-01-09. PMID:16958574. |
the treatment of psychogenic polydipsia with risperidone in two children diagnosed with schizophrenia. |
2007-01-09 |
2023-08-12 |
Not clear |
| Edoardo Spina, Concetta D'Arrigo, Gaetana Migliardi, Vincenza Santoro, Maria Rosaria Muscatello, Umberto Micò, Giuseppina D'Amico, Emilio Perucc. Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder. Therapeutic drug monitoring. vol 28. issue 5. 2007-01-09. PMID:17038872. |
effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder. |
2007-01-09 |
2023-08-12 |
Not clear |